113 related articles for article (PubMed ID: 7073250)
21. Treatment of myopathic carnitine deficiency: quantitation of response to prednisone and carnitine.
Griggs RC; Pandya S; Moxley RT; Forbes G; VanDyke DH; Pearce FJ
Trans Am Neurol Assoc; 1981; 106():199-202. PubMed ID: 7348994
[No Abstract] [Full Text] [Related]
22. [Systemic carnitine deficiency: its place in Reye's syndrome (author's transl)].
Chapoy P; Angelini C; Cederbaum S
Nouv Presse Med; 1981 Feb; 10(7):499-502. PubMed ID: 7232195
[TBL] [Abstract][Full Text] [Related]
23. [Carnitine deficiency in inborn errors of metabolism].
Sela BA; Lerman-Sagie T; Berkovitz M
Harefuah; 1997 Nov; 133(10):419-23, 504. PubMed ID: 9418309
[TBL] [Abstract][Full Text] [Related]
24. [Congenital myopathy with lipid and glycogen overload of muscle fiber and partial deficit of carnitine].
Gilly R; Carrier H; Lamit J
Ann Pediatr (Paris); 1980 May; 27(5):319-24. PubMed ID: 6940512
[No Abstract] [Full Text] [Related]
25. [Carnitine-deficient cardiomyopathy].
Kádár K; Melegh B; Szendrei E; Herczegfalvi A
Orv Hetil; 1994 Feb; 135(9):473-4. PubMed ID: 8139852
[TBL] [Abstract][Full Text] [Related]
26. Severe muscle-eye-brain disease is associated with a homozygous mutation in the POMGnT1 gene.
Teber S; Sezer T; Kafali M; Manzini MC; Konuk Yüksel B; Tekin M; Fitöz S; Walsh CA; Deda G
Eur J Paediatr Neurol; 2008 Mar; 12(2):133-6. PubMed ID: 17881266
[TBL] [Abstract][Full Text] [Related]
27. Clinical genetics conference: progress in understanding muscle disease.
Schmickel RD
J Pediatr; 1986 Dec; 109(6):1071-3. PubMed ID: 3783334
[No Abstract] [Full Text] [Related]
28. Novel OCTN2 mutations: no genotype-phenotype correlations: early carnitine therapy prevents cardiomyopathy.
Lamhonwah AM; Olpin SE; Pollitt RJ; Vianey-Saban C; Divry P; Guffon N; Besley GT; Onizuka R; De Meirleir LJ; Cvitanovic-Sojat L; Baric I; Dionisi-Vici C; Fumic K; Maradin M; Tein I
Am J Med Genet; 2002 Aug; 111(3):271-84. PubMed ID: 12210323
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic difficulties in a case of primary systemic carnitine deficiency with idiopathic dilated cardiomyopathy.
Kinali M; Olpin SE; Clayton PT; Daubeney PE; Mercuri E; Manzur AY; Tein I; Leonard J; Muntoni F
Eur J Paediatr Neurol; 2004; 8(4):217-9. PubMed ID: 15261886
[TBL] [Abstract][Full Text] [Related]
30. "Lipid storage myopathy" with muscle carnitine deficiency only.
Buscaino GA; Marolda M; Borgia A; Cocchiararo M; Scarafile P
Acta Neurol (Napoli); 1982 Feb; 4(1):1-13. PubMed ID: 7090864
[No Abstract] [Full Text] [Related]
31. Familial carnitine deficiency: further evidence for autosomal recessive transmission with variable expression.
Shahar E; Brand N; Shapira Y; Barash V; Gutman A
J Neurol Neurosurg Psychiatry; 1988 Feb; 51(2):298-300. PubMed ID: 3346699
[TBL] [Abstract][Full Text] [Related]
32. Carnitine deficiency during valproic acid treatment.
Van Wouwe JP
Int J Vitam Nutr Res; 1995; 65(3):211-4. PubMed ID: 8830002
[TBL] [Abstract][Full Text] [Related]
33. [Familial carnitine deficiency].
Yorifuji S
Ryoikibetsu Shokogun Shirizu; 2001; (36):47-50. PubMed ID: 11596440
[No Abstract] [Full Text] [Related]
34. Two novel missense mutations of the OCTN2 gene (W283R and V446F) in a patient with primary systemic carnitine deficiency.
Mayatepek E; Nezu J; Tamai I; Oku A; Katsura M; Shimane M; Tsuji A
Hum Mutat; 2000 Jan; 15(1):118. PubMed ID: 10612840
[TBL] [Abstract][Full Text] [Related]
35. Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter.
Nezu J; Tamai I; Oku A; Ohashi R; Yabuuchi H; Hashimoto N; Nikaido H; Sai Y; Koizumi A; Shoji Y; Takada G; Matsuishi T; Yoshino M; Kato H; Ohura T; Tsujimoto G; Hayakawa J; Shimane M; Tsuji A
Nat Genet; 1999 Jan; 21(1):91-4. PubMed ID: 9916797
[TBL] [Abstract][Full Text] [Related]
36. Functional analysis of mutations in the OCTN2 transporter causing primary carnitine deficiency: lack of genotype-phenotype correlation.
Wang Y; Taroni F; Garavaglia B; Longo N
Hum Mutat; 2000 Nov; 16(5):401-7. PubMed ID: 11058897
[TBL] [Abstract][Full Text] [Related]
37. [Value and significance of various clinical chemistry tests in diagnosing genetically based metabolic myopathies and encephalopathies].
Bertagnolio B; Rimoldi M; Cardace G; Bottacchi E; Di Donato S
Riv Neurobiol; 1981; 27(34):760-5. PubMed ID: 7052687
[No Abstract] [Full Text] [Related]
38. Exclusive cardiac dysfunction in familial primary carnitine deficiency cases: a genotype-phenotype correlation.
Yamak A; Bitar F; Karam P; Nemer G
Clin Genet; 2007 Jul; 72(1):59-62. PubMed ID: 17594400
[No Abstract] [Full Text] [Related]
39. Serum carnitine levels in children with iron-deficiency anemia with or without pica.
Citak EC; Citak FE; Kurekci AE
Pediatr Hematol Oncol; 2006; 23(5):381-5. PubMed ID: 16728358
[TBL] [Abstract][Full Text] [Related]
40. Lafora's disease--a distinct genetically determined form of Unverricht's syndrome.
Yanoff M; Schwarz GA
J Genet Hum; 1965 Sep; 14(2):235-44. PubMed ID: 5849253
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
